The management of thirty immunocompromised patients with tuberculosis

B. Dautzenberg, J. Grosset, J. Fechner, J. Lucciani, P. Debre, S. Herson, C. Truffot, C. Sors

Research output: Contribution to journalArticle

Abstract

Between 1978 and 1981, 30 of 870 bacteriologically confirmed cases of tuberculosis occurred in immunocompromised hosts. One year after the diagnosis, 11 patients were dead, only 2 of them of tuberculosis. In the other 19 patients, the course of tuberculosis under standard chemotherapy was the same as in nonimmunocompromised hosts. Among the 24 patients still alive more than 2 months after the diagnosis of tuberculosis, the treatment of the underlying disease was changed in 14 patients to avoid worsening of the course of the tuberculosis; 5 patients died and 4 kidney transplant carriers rejected their transplants. The treatment of the underlying disease was not changed in 10 patients: all of these remained alive 1 yr later, and 2 were kidney transplant carrier who did not reject their transplants. We conclude that the clinical response of the immunocompromised tuberculous host was good and that treatment of the underlying disease should not be modified.

Original languageEnglish (US)
Pages (from-to)494-496
Number of pages3
JournalAmerican Review of Respiratory Disease
Volume129
Issue number3
StatePublished - 1984
Externally publishedYes

Fingerprint

Immunocompromised Host
Tuberculosis
Transplants
Kidney
Therapeutics
Drug Therapy

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Dautzenberg, B., Grosset, J., Fechner, J., Lucciani, J., Debre, P., Herson, S., ... Sors, C. (1984). The management of thirty immunocompromised patients with tuberculosis. American Review of Respiratory Disease, 129(3), 494-496.

The management of thirty immunocompromised patients with tuberculosis. / Dautzenberg, B.; Grosset, J.; Fechner, J.; Lucciani, J.; Debre, P.; Herson, S.; Truffot, C.; Sors, C.

In: American Review of Respiratory Disease, Vol. 129, No. 3, 1984, p. 494-496.

Research output: Contribution to journalArticle

Dautzenberg, B, Grosset, J, Fechner, J, Lucciani, J, Debre, P, Herson, S, Truffot, C & Sors, C 1984, 'The management of thirty immunocompromised patients with tuberculosis', American Review of Respiratory Disease, vol. 129, no. 3, pp. 494-496.
Dautzenberg B, Grosset J, Fechner J, Lucciani J, Debre P, Herson S et al. The management of thirty immunocompromised patients with tuberculosis. American Review of Respiratory Disease. 1984;129(3):494-496.
Dautzenberg, B. ; Grosset, J. ; Fechner, J. ; Lucciani, J. ; Debre, P. ; Herson, S. ; Truffot, C. ; Sors, C. / The management of thirty immunocompromised patients with tuberculosis. In: American Review of Respiratory Disease. 1984 ; Vol. 129, No. 3. pp. 494-496.
@article{e2bbfcebfe744e7a97e8ef1aff9ecf2c,
title = "The management of thirty immunocompromised patients with tuberculosis",
abstract = "Between 1978 and 1981, 30 of 870 bacteriologically confirmed cases of tuberculosis occurred in immunocompromised hosts. One year after the diagnosis, 11 patients were dead, only 2 of them of tuberculosis. In the other 19 patients, the course of tuberculosis under standard chemotherapy was the same as in nonimmunocompromised hosts. Among the 24 patients still alive more than 2 months after the diagnosis of tuberculosis, the treatment of the underlying disease was changed in 14 patients to avoid worsening of the course of the tuberculosis; 5 patients died and 4 kidney transplant carriers rejected their transplants. The treatment of the underlying disease was not changed in 10 patients: all of these remained alive 1 yr later, and 2 were kidney transplant carrier who did not reject their transplants. We conclude that the clinical response of the immunocompromised tuberculous host was good and that treatment of the underlying disease should not be modified.",
author = "B. Dautzenberg and J. Grosset and J. Fechner and J. Lucciani and P. Debre and S. Herson and C. Truffot and C. Sors",
year = "1984",
language = "English (US)",
volume = "129",
pages = "494--496",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "3",

}

TY - JOUR

T1 - The management of thirty immunocompromised patients with tuberculosis

AU - Dautzenberg, B.

AU - Grosset, J.

AU - Fechner, J.

AU - Lucciani, J.

AU - Debre, P.

AU - Herson, S.

AU - Truffot, C.

AU - Sors, C.

PY - 1984

Y1 - 1984

N2 - Between 1978 and 1981, 30 of 870 bacteriologically confirmed cases of tuberculosis occurred in immunocompromised hosts. One year after the diagnosis, 11 patients were dead, only 2 of them of tuberculosis. In the other 19 patients, the course of tuberculosis under standard chemotherapy was the same as in nonimmunocompromised hosts. Among the 24 patients still alive more than 2 months after the diagnosis of tuberculosis, the treatment of the underlying disease was changed in 14 patients to avoid worsening of the course of the tuberculosis; 5 patients died and 4 kidney transplant carriers rejected their transplants. The treatment of the underlying disease was not changed in 10 patients: all of these remained alive 1 yr later, and 2 were kidney transplant carrier who did not reject their transplants. We conclude that the clinical response of the immunocompromised tuberculous host was good and that treatment of the underlying disease should not be modified.

AB - Between 1978 and 1981, 30 of 870 bacteriologically confirmed cases of tuberculosis occurred in immunocompromised hosts. One year after the diagnosis, 11 patients were dead, only 2 of them of tuberculosis. In the other 19 patients, the course of tuberculosis under standard chemotherapy was the same as in nonimmunocompromised hosts. Among the 24 patients still alive more than 2 months after the diagnosis of tuberculosis, the treatment of the underlying disease was changed in 14 patients to avoid worsening of the course of the tuberculosis; 5 patients died and 4 kidney transplant carriers rejected their transplants. The treatment of the underlying disease was not changed in 10 patients: all of these remained alive 1 yr later, and 2 were kidney transplant carrier who did not reject their transplants. We conclude that the clinical response of the immunocompromised tuberculous host was good and that treatment of the underlying disease should not be modified.

UR - http://www.scopus.com/inward/record.url?scp=0021350914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021350914&partnerID=8YFLogxK

M3 - Article

VL - 129

SP - 494

EP - 496

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 3

ER -